Loading clinical trials...
Loading clinical trials...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, ranging from pure steatosis to non-alcoholic steatohepatitis and ultimately to liver cirrhosis. In order to study the association between NAFLD and nephrolithiasis while minimizing the confounding effect of metabolic syndrome, we investigated the impact of different degrees of NAFLD severity on potential risk factors for stone formation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Fondazione Policlinico A.Gemelli IRCCS
Roma, Italy
Start Date
July 19, 2019
Primary Completion Date
April 30, 2022
Completion Date
November 30, 2022
Last Updated
April 10, 2024
42
ACTUAL participants
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT06599918
NCT06218589
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions